{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Clozapine, one of a new generation of anti-psychotic drugs, has become the first psychiatric medication to win federal approval as a treatment for suicidal behavior. The Food and Drug Administration announced yesterday that the agency had approved the drug for treating recurrent suicidal thoughts or suicide attempts in patients with schizophrenia, a devastating illness that afflicts 1 of 100 Americans.", "headline": {"main": "Anti-Psychotic Approved To Treat Suicidal Behavior"}, "abstract": "Food and Drug Adm approves clozapine, one of new generation of anti-psychotic drugs, for treating recurrent suicidal thoughts or suicide attempts in patients with schizophrenia; clinical trial conducted by Novartis finds that over two years suicidal patients taking clozapine made fewer suicide attempts and required fewer hospitalizations to prevent suicide than similar patients taking olanzapine, another of new generation of drugs (M)", "print_page": "30", "word_count": 636, "_id": "4fd23cf18eb7c8105d7d2a52", "snippet": "Clozapine, one of a new generation of anti-psychotic drugs, has become the first psychiatric medication to win federal approval as a treatment for suicidal behavior.    The Food and Drug Administration announced yesterday that the agency had approved...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/20/us/anti-psychotic-approved-to-treat-suicidal-behavior.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "NOVARTIS AG"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "OLANZAPINE (DRUG)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "CLOZAPINE (DRUG)"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Erica", "lastname": "GOODE"}], "original": "By ERICA GOODE"}, "document_type": "article", "pub_date": "2002-12-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Many experts have told doctors for years that diuretics, a type of medicine that costs just pennies a day, are the best drugs to treat high blood pressure. But those recommendations have been nearly drowned out by the major drug companies, which have poured hundreds of millions of dollars into marketing their newer and higher-priced blood pressure medicines, particularly calcium channel blockers and ACE inhibitors.", "headline": {"main": "Diuretics' Value Drowned Out By Trumpeting of Newer Drugs"}, "abstract": "Many experts have told doctors for years that diuretics are best drugs to treat high blood pressure, but those recommendations have been nearly drowned out by major drug companies, which have poured hundreds of millions of dollars into marketing their newer and much pricier blood pressure medicines, particularly calcium channel blockers and ACE inhibitors; analysts say results of government study validating diuretics will have little effect on sales of newer drugs, in part because drug makers will continue to urge doctors to prescribe their medicines as additional treatments for heart patients who need more than one drug to control their blood pressure (M)", "print_page": "32", "word_count": 600, "_id": "4fd2233b8eb7c8105d7a8dcd", "snippet": "Many experts have told doctors for years that diuretics, a type of medicine that costs just pennies a day, are the best drugs to treat high blood pressure.    But those recommendations have been nearly drowned out by the major drug companies, which...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/18/us/diuretics-value-drowned-out-by-trumpeting-of-newer-drugs.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "CALCIUM CHANNEL BLOCKER (DRUG)"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ACE INHIBITORS (DRUGS)"}, {"name": "subject", "value": "BLOOD PRESSURE"}, {"name": "subject", "value": "DIURETICS (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-12-18T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Note: This lesson was originally published on an older version of The Learning Network; the link to the related Times article will take you to a page on the old site.", "headline": {"main": "Medicine Show", "kicker": "The Learning Network"}, "abstract": "In this lesson, students gather anecdotal evidence about various herbal remedies' abilities to cure ailments, develop hypotheses from these observations, and design scientifically valid experiments that could prove their suppositions.", "print_page": null, "word_count": 2398, "_id": "4fd363c18eb7c8105d8b2611", "snippet": "In this lesson, students gather anecdotal evidence about various herbal remedies' abilities to cure ailments, develop hypotheses from these observations, and design scientifically valid experiments that could prove their suppositions.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2002/12/17/medicine-show/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Clayton", "lastname": "DEKORNE"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Bridget", "lastname": "ANDERSON"}], "original": "By CLAYTON DEKORNE and BRIDGET ANDERSON"}, "document_type": "blogpost", "pub_date": "2002-12-17T02:56:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Among workers 50 to 70 years old who said they lost money in the stock market in the last two years, about one in five said they had postponed retirement because of the losses, according to a survey released today. The stock market decline has had a ''sobering effect'' on older Americans, according to the study released by AARP, formerly known as the American Association of Retired Persons, with three-quarters of those who lost money in the market saying that their losses had altered their standard of living, work plans or expectations about retirement.", "headline": {"main": "Bumpy Market Has Many Delaying Retirement, Survey Finds"}, "abstract": null, "print_page": "11", "word_count": 454, "_id": "4fd26ce58eb7c8105d825b02", "snippet": "Among workers 50 to 70 years old who said they lost money in the stock market in the last two years, about one in five said they had postponed retirement because of the losses, according to a survey released today.    The stock market decline has had...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/17/business/bumpy-market-has-many-delaying-retirement-survey-finds.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2002-12-17T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "An elderly woman complaining of fatigue and depressed mood sees her internist, who diagnoses depression and prescribes Prozac. So far, so good. But one month later, when getting out of bed, she faints and hits the floor, breaking several ribs. This woman, it turns out, was also taking a small dose of an older sedating antidepressant, Elavil, for insomnia. Though her doctor knew this, he was unaware that Prozac could effectively double or triple the concentration of Elavil in her blood, lowering her blood pressure and causing her to faint. Luckily, her injury wasn't fatal.", "headline": {"main": "Curing and Killing: The Perils of a Growing Medicine Cabinet", "kicker": "ESSAY"}, "abstract": "Dr Richard A Friedman Essay on rise in risk of drug interactions; describes roles doctors, nurses, pharmacists and patients could play in preventing adverse drug reactions; notes herbal remedies, supplements, smoking, certain foods and recreational drugs can play significant roles in how body reacts to newly prescribed drugs; drawing (M)", "print_page": "6", "word_count": 893, "_id": "4fd28c5c8eb7c8105d860b8e", "snippet": "An elderly woman complaining of fatigue and depressed mood sees her internist, who diagnoses depression and prescribes Prozac. So far, so good. But one month later, when getting out of bed, she faints and hits the floor, breaking several ribs.   ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/17/health/essay-curing-and-killing-the-perils-of-a-growing-medicine-cabinet.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Richard", "middlename": "A.", "lastname": "FRIEDMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RICHARD A. FRIEDMAN, M.D"}, "document_type": "article", "pub_date": "2002-12-17T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Outlook", "lead_paragraph": "VANILLA will be the scent of the year for 2003, according to Mintel, a research company, and citrus the flavor of the year. Green in all shades will be the color in home furnishings for 2003, the trade association Cotton Inc. says. But when it comes to forecasts for advertising spending, the crystal ball clouds over. As one of the most unsettled years in memory comes to a bumpy conclusion, Madison Avenue is anticipating an improvement; big advertisers -- buoyed by an economy that by some measures appears to be emerging from its sluggishness -- are looking to increase their marketing budgets.", "headline": {"main": "Technology & Media: Advertising; People Are Talking About Looser Wallets"}, "abstract": "Spending by companies on advertising through all media is forecast to increase by 3 percent to 4 percent in 2003, rescuing ad industry from bleak fortunes of recent years; photos (M)", "print_page": "15", "word_count": 1259, "_id": "4fd28c618eb7c8105d860f4a", "snippet": "VANILLA will be the scent of the year for 2003, according to Mintel, a research company, and citrus the flavor of the year. Green in all shades will be the color in home furnishings for 2003, the trade association Cotton Inc. says. But when it comes...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/12/16/news/technology-media-advertising-people-are-talking-about-looser-wallets.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "ADVERTISING (TIMES COLUMN)"}, {"name": "subject", "value": "ADVERTISING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Stuart", "lastname": "ELLIOTT"}], "original": "By STUART ELLIOTT"}, "document_type": "article", "pub_date": "2002-12-16T00:00:00Z", "section_name": null}], "meta": {"hits": 6, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}